IVAX PHARMACEUTICALS INC | Teva Pharmaceutical Industries | air pollution violation | 2007 | NJ-ENV | $6,000 |
PLIVA INC | Teva Pharmaceutical Industries | water pollution violation | 2007 | NJ-ENV | $15,000 |
Morton Grove Pharmaceuticals, Inc. | Wockhardt Limited | campaign finance violation | 2007 | FEC | $9,000 |
Merck & Co. | Merck | drug or medical equipment safety violation | 2007 | private lawsuit-federal | $4,850,000,000 |
Eli Lilly and Company | Eli Lilly | drug or medical equipment safety violation | 2007 | private lawsuit-federal | $500,000,000 |
AstraZeneca | AstraZeneca | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $24,000,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $2,100,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $70,000,000 |
Warner Chilcott Holdings Company | AbbVie | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
Warner Chilcott Holdings Company | AbbVie | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $2,100,000 |
CAMBREX CHARLES CITY, INC. | Cambrex | workplace safety or health violation | 2007 | OSHA | $6,375 |
Merck Sharp & Dohme Quimica de Puerto Rico | Merck | hazardous waste violation | 2007 | EPA | $10,000 |
SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. ( SB) | Merck | environmental violation | 2007 | EPA | $40,950 |
SIGMA ALDRICH MFG LLC | Merck KGaA (EMD) | air pollution violation | 2007 | EPA | $55,000 |
Amgen Inc. | Amgen | hazardous waste violation | 2007 | EPA | $24,368 |
PHIBRO-TECH, INC. | Phibro Animal Health | railroad safety violation | 2008 | FRA | $5,650 |
Cephalon Inc | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2008 | FDA | $425,000,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | off-label or unapproved promotion of medical products | 2008 | FDA | $4,000,000 |
Merck & Company | Merck | False Claims Act and related | 2008 | DOJ_CIVIL | $650,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | air pollution violation | 2008 | EPA | $3,650,000 |
Pfizer Inc. | Pfizer | air pollution violation | 2008 | EPA | $975,000 |
Biovail Corporation | Bausch Health | accounting fraud or deficiencies | 2008 | SEC | $10,000,000 |
Merck & Co., Inc. | Merck | labor relations violation | 2008 | NLRB | $100,000 |
Johnson & Johnson | Johnson & Johnson | Controlled Substances Act violation | 2008 | USAO | $511,000 |
AstraZeneca | AstraZeneca | employment discrimination | 2008 | private lawsuit-state | $350,000 |
Abbott Laboratories | AbbVie | False Claims Act and related | 2008 | PA-AG | $6,950,000 |
Abbott Laboratories Inc. | AbbVie | False Claims Act and related | 2008 | TX-AG | $28,000,000 |
Amgen and Immunex | Amgen | False Claims Act and related | 2008 | AL-AG | $3,500,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2008 | WI-AG | $2,000,000 |
Barr Pharmaceuticals | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $5,900,000 |
Boehringer Ingelheim Roxane, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2008 | MA-AG | $1,800,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2008 | AL-AG | $11,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
Bristol-Myers Squibb Company and Apothecon, Inc. | Bristol-Myers Squibb | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
Cephalon Inc. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2008 | CT-AG | $6,150,000 |
Dey L.P. | Viatris | False Claims Act and related | 2008 | AL-AG | $4,750,000 |
Eli Lilly and Company | Eli Lilly | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | $62,000,000 |
Merck | Merck | False Claims Act and related | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $290,000,000 |
Merck & Co. | Merck | consumer protection violation | 2008 | MULTI-AG | $58,000,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,700,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | $60,000,000 |
Purdue Frederick Co. | Purdue Pharma | False Claims Act and related | 2008 | TX-AG | $1,600,000 |
Roxanne Laboratories and Boehringer Ingelheim | Hikma Pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $9,500,000 |
Schering-Plough | Merck | False Claims Act and related | 2008 | MO-AG | $31,000,000 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2008 | AL-AG | $2,000,000 |
Mallinckrodt, Inc. | Mallinckrodt | radioactive waste violation | 2008 | GA-ENV | $5,000 |
PLIVA INC | Teva Pharmaceutical Industries | air pollution violation | 2008 | NJ-ENV | $5,600 |
EMD Chemicals Inc. | Merck KGaA (EMD) | environmental violation | 2008 | OH-ENV | $30,700 |
Pfizer | Pfizer | drug or medical equipment safety violation | 2008 | private lawsuit-federal | $745,000,000 |
GlaxoSmithKline | GlaxoSmithKline | drug or medical equipment safety violation | 2008 | private lawsuit-federal | $40,000,000 |
Hoffmann-La Roche Inc. | Roche | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $11,000,000 |
Warner Chilcott Holdings Company | AbbVie | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $9,000,000 |
PERRIGO COMPANY OF SOUTH CAROLINA | Perrigo | workplace safety or health violation | 2008 | OSHA | $5,000 |
PFIZER GLOBAL MANUFACTURING | Pfizer | air pollution violation | 2008 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $975,000 |
Wyeth Rouses Point | Pfizer | water pollution violation | 2008 | EPA | $44,500 |
Bristol Myers Squibb Company | Bristol-Myers Squibb | air pollution violation | 2008 | EPA | $66,770 |
Bristol Myers Squibb Manufacturing Company | Bristol-Myers Squibb | hazardous waste violation | 2008 | EPA | $52,000 |
Merck and Company | Merck | water pollution violation | 2008 | EPA | $6,075,000 |
Phibro-Tech, Inc. | Phibro Animal Health | hazardous waste violation | 2008 | EPA | $151,603 |
ABBOTT LABORATORIES | Abbott Laboratories | hazardous waste violation | 2008 | EPA | $25,033 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2009 | FTC | $2,100,000 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | DOJ_CIVIL | $14,000,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
Mylan Pharmaceuticals and UDL Laboratories | Viatris | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
Ortho McNeil Pharmaceutical | Johnson & Johnson | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
Eli Lilly and Company | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
Novo Nordisk A/S | Novo Holdings A/S | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
Novo Nordisk A/S | Novo Holdings A/S | Foreign Corrupt Practices Act | 2009 | SEC | $9,030,149 |
St Jude Medical Inc | Abbott Laboratories | wage and hour violation | 2009 | WHD | $17,662 |
Abbott Laboratories Puerto Rico, Inc. | Abbott Laboratories | wage and hour violation | 2009 | WHD | $49,045 |
Biogen Idec, Inc. | Biogen | wage and hour violation | 2009 | WHD | $49,600 |
Merck and Company, Inc. | Merck | labor relations violation | 2009 | NLRB | $10,710 |
Biovail Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2009 | USAO | $24,647,876 |
Pfizer | Pfizer | employment discrimination | 2009 | private lawsuit-federal | $1,365,003 |
Abbott Laboratories | AbbVie | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Abbott Laboratories Inc. | AbbVie | False Claims Act and related | 2009 | OH-AG | $1,340,000 |
Abbott Laboratories, Inc. | AbbVie | False Claims Act and related | 2009 | IA-AG | $357,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2009 | IL-AG | $7,200,000 |
Amgen, Inc. | Amgen | False Claims Act and related | 2009 | IA-AG | $357,000 |
Amgen, Inc. | Amgen | False Claims Act and related | 2009 | KY-AG | $2,400,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
Aventis Pharmaceutical L.P. | Sanofi | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
Boehringer Ingelheim Roxane, Inc. et al. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Dey Labs | Viatris | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
Eli Lilly and Co. | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | CT-AG | $25,100,000 |
Eli Lilly and Co. | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | ID-AG | $13,000,000 |
Eli Lilly and Company | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456 |
Forest Laboratories | AbbVie | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
GlaxoSmithKline | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
Immunex Corp. | Amgen | False Claims Act and related | 2009 | IA-AG | $357,000 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $5,400,000 |
Johnson and Johnson | Johnson & Johnson | consumer protection violation | 2009 | WV-AG | $4,475,000 |